Cargando…
Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada
SIMPLE SUMMARY: Despite significant advancements in the treatment of metastatic prostate cancer, a validated prognostic tool for patients with de novo metastatic castration-sensitive prostate cancer (mCSPC) is still lacking. Using population-based data from Ontario, Canada, we examined the prognosti...
Autores principales: | Wallis, Christopher J. D., Shayegan, Bobby, Morgan, Scott C., Hamilton, Robert J., Cagiannos, Ilias, Basappa, Naveen S., Ferrario, Cristiano, Gotto, Geoffrey T., Fernandes, Ricardo, Roy, Soumyajit, Noonan, Krista L., Niazi, Tamim, Hotte, Sebastien J., Saad, Fred, Hew, Huong, Chan, Katherine F. Y., Park-Wyllie, Laura, Malone, Shawn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200983/ https://www.ncbi.nlm.nih.gov/pubmed/34200349 http://dx.doi.org/10.3390/cancers13112844 |
Ejemplares similares
-
Real-World Use of Androgen-Deprivation Therapy: Intensification Among
Older Canadian Men With de Novo Metastatic Prostate Cancer
por: Wallis, Christopher J D, et al.
Publicado: (2021) -
Patterns of care for non‐metastatic castration‐resistant prostate cancer: A population‐based study
por: Malone, Shawn, et al.
Publicado: (2022) -
Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report
por: Chandhoke, Gursimran, et al.
Publicado: (2018) -
Implications of local failure on overall prognosis in aggressive prostate cancer
por: Mula-Hussain, Layth, et al.
Publicado: (2020) -
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
por: Small, E J, et al.
Publicado: (2019)